{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "14754758", "DateCompleted": {"Year": "2004", "Month": "06", "Day": "29"}, "DateRevised": {"Year": "2013", "Month": "11", "Day": "21"}, "Article": {"Language": ["eng"], "ELocationID": [], "ArticleDate": [{"Year": "2004", "Month": "01", "Day": "30"}], "Journal": {"ISSN": "1044-1549", "JournalIssue": {"Volume": "30", "Issue": "6", "PubDate": {"Year": "2004", "Month": "Jun"}}, "Title": "American journal of respiratory cell and molecular biology", "ISOAbbreviation": "Am J Respir Cell Mol Biol"}, "ArticleTitle": "Interleukin-1 receptor antagonist attenuates airway hyperresponsiveness following exposure to ozone.", "Pagination": {"StartPage": "830", "EndPage": "836", "MedlinePgn": "830-6"}, "Abstract": {"AbstractText": ["The role of an interleukin (IL)-1 receptor antagonist (IL-1Ra) on the development of airway hyperresponsiveness (AHR) and airway inflammation following acute O(3) exposure in mice was investigated. Exposure of C57/BL6 mice to O(3) at a concentration of 2.0 ppm or filtered air for 3 h resulted in increases in airway responsiveness to inhaled methacholine (MCh) 8 and 16 h after the exposure, and an increase in neutrophils in the bronchoalveolar lavage (BAL) fluid. IL-1beta expression, assessed by gene microarray, was increased 2-fold 4 h after O(3) exposure, and returned to baseline levels by 24 h. Levels of IL-1beta in lung homogenates were also increased 8 h after O(3) exposure. Administration of (human) IL-1Ra before and after O(3) exposure prevented development of AHR and decreased BAL fluid neutrophilia. Increases in chemokine levels in lung homogenates, tumor necrosis factor-alpha, MIP-2, and keratinocyte chemoattractant following O(3) exposure were prevented by IL-1Ra. Inhalation of dexamethasone, an inhibitor of IL-1 production, blocked the development of AHR, BAL fluid neutrophilia, and decreased levels of IL-1 following O(3) exposure. In summary, acute exposure to O(3) induces AHR, neutrophilic inflammation, epithelial damage, and IL-1. An IL-1Ra effectively prevents the development of altered airway function, inflammation, and structural damage."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pediatrics, National Jewish Medical and Research Center, 1400 Jackson Street, Denver, CO 80206, USA."}], "Identifier": [], "LastName": "Park", "ForeName": "Jung-Won", "Initials": "JW"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Taube", "ForeName": "Christian", "Initials": "C"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Swasey", "ForeName": "Christina", "Initials": "C"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Kodama", "ForeName": "Taku", "Initials": "T"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Joetham", "ForeName": "Anthony", "Initials": "A"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Balhorn", "ForeName": "Annette", "Initials": "A"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Takeda", "ForeName": "Katsuyuki", "Initials": "K"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Miyahara", "ForeName": "Nobuaki", "Initials": "N"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Allen", "ForeName": "Corrie B", "Initials": "CB"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Dakhama", "ForeName": "Azzeddine", "Initials": "A"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Kim", "ForeName": "Soo-Hyun", "Initials": "SH"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Dinarello", "ForeName": "Charles A", "Initials": "CA"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Gelfand", "ForeName": "Erwin W", "Initials": "EW"}], "GrantList": [{"GrantID": "AI-15614", "Acronym": "AI", "Agency": "NIAID NIH HHS", "Country": "United States"}, {"GrantID": "HL-36577", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}, {"GrantID": "HL-61005", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}, {"GrantID": "HL-68743", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, U.S. Gov't, Non-P.H.S.", "Research Support, U.S. Gov't, P.H.S."]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Am J Respir Cell Mol Biol", "NlmUniqueID": "8917225", "ISSNLinking": "1044-1549"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Bronchoconstrictor Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Cytokines"}, {"RegistryNumber": "0", "NameOfSubstance": "Glucocorticoids"}, {"RegistryNumber": "0", "NameOfSubstance": "Interleukin-1"}, {"RegistryNumber": "0", "NameOfSubstance": "Oxidants, Photochemical"}, {"RegistryNumber": "0", "NameOfSubstance": "Receptors, Interleukin-1"}, {"RegistryNumber": "0W5ETF9M2K", "NameOfSubstance": "Methacholine Chloride"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}, {"RegistryNumber": "7S5I7G3JQL", "NameOfSubstance": "Dexamethasone"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["immunology"], "DescriptorName": "Bronchial Hyperreactivity"}, {"QualifierName": ["chemistry", "cytology"], "DescriptorName": "Bronchoalveolar Lavage Fluid"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Bronchoconstrictor Agents"}, {"QualifierName": ["metabolism"], "DescriptorName": "Cytokines"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Dexamethasone"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Gene Expression Profiling"}, {"QualifierName": [], "DescriptorName": "Gene Expression Regulation"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Glucocorticoids"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "Interleukin-1"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Methacholine Chloride"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred C57BL"}, {"QualifierName": ["immunology", "metabolism"], "DescriptorName": "Neutrophils"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Oxidants, Photochemical"}, {"QualifierName": ["immunology", "pharmacology"], "DescriptorName": "Ozone"}, {"QualifierName": ["antagonists & inhibitors", "immunology"], "DescriptorName": "Receptors, Interleukin-1"}, {"QualifierName": ["cytology", "drug effects", "metabolism", "pathology"], "DescriptorName": "Respiratory Mucosa"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2004", "Month": "2", "Day": "3", "Hour": "5", "Minute": "0"}, {"Year": "2004", "Month": "6", "Day": "30", "Hour": "5", "Minute": "0"}, {"Year": "2004", "Month": "2", "Day": "3", "Hour": "5", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["14754758", "10.1165/rcmb.2003-0373OC", "2003-0373OC"]}}], "PubmedBookArticle": []}